Advertisement

Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

I-Mab Biopharma Co., Ltd. (Shanghai: IMAB)

I-Mab is a dynamic and fast-growing global player committed to developing innovative biologics in the areas of immuno-oncology and immuno-inflammation through internal R&D capabilities and global partnerships. I-Mab's pipeline is driven by the company's development strategy to address unmet needs in China and to bring innovative assets to the world. Following the recent Series B financing of $150 million and rapid growth in internal R&D capabilities, I-Mab is now well positioned to advance its China portfolio of multiple Phase 2 and Phase 3 innovative clinical assets and its global portfolio of first-in-class and best-in-class assets in China and/or US in 2018. I-Mab's long-term commitment is to deliver transformational medicines to patients globally with a focus on unmet needs in China. *

 

Period Start 2017-11-30 existent
  Group I-Mab (Group)
Products Industry biopharmaceutical
  Industry 2 drug development
Persons Person Zang, Jingwu (I-Mab 201711 CEO + Founder of I-Mab Biopharma before GSK RnD China 200705 Head)
  Person 2 Lin, Raven (I-Mab 201711 Head of Business Development at I-Mab Biopharma)
     
Region Region Shanghai
  Country China
  City n. a. 
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: MorphoSys AG. (11/30/17). "Press Release: MorphoSys Signs Regional License Agreement for Antibody MOR202 with I-Mab". Planegg.
     
   
Record changed: 2020-08-24

Advertisement

Picture [iito] Made Without Love 650x80px

More documents for I-Mab (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px




» top